Regular aspirin use leads to significant reductions in the risk of cancer, metastasis, and cancer mortality, reports a meta-analysis involving more than 100,000 study subjects.
A number of studies contribute to the growing evidence base suggesting that daily aspirin can be used to help prevent and possibly treat cancer. Peter M Rothwell, from the University of Oxford of that United Kingdom), and colleagues conducted a meta-analysis covering 51 clinical trials and involving more than 100,000 study subjects. Overall, aspirin users had a 38% reduction in the risk of colorectal and other gastrointestinal cancers, as compared to nonusers. Cancer mortality was 15% lower among regular use of aspirin. Cancer metastasis was 35 to 40% less common. The study authors conclude that: “aspirin use leads to significant reductions in the risk of cancer, metastasis, and cancer mortality.”
